Millions of people worldwide suffer from tuberculosis, Chagas disease, and fungal infections, yet current treatment is expensive and minimally effective.
To combat these diseases, researcher Pablo Sobrado is developing drugs that may be able to help stop the illnesses in some of the poorest parts of the world.
“Our work is focused on understanding these diseases so that we can develop treatments that are not only effective, but affordable,” Sobrado said.
In addition to operating an infectious disease research program, Sobrado also serves on the steering committee of Virginia Tech’s Center for Drug Discovery and as the director of the center’s screening lab, located in the Fralin Life Science Institute. Formed in 2012, the center’s mission is to accelerate research that could lead to new treatments for cancer, Alzheimer’s disease, tuberculosis, fungal infections, cardiovascular disease, atherosclerosis, diseases of the central nervous system, and parasitic diseases such as malaria and Chagas disease.